P602. Do Antipsychotics Suppress Cancer initiation? Identification of Novel off Target Effects of Typical Antipsychotics Using Epidemiology, Bioinformatics, and Protein-Kinase Activity
Abdul‐rizaq Hamoud(ProMedica Toledo Hospital), Robert E. McCullumsmith(Neurosciences Institute), Ali Sajid Imami(University of Toledo), Jacob Rethman(University of Toledo), James Reigle(Cincinnati Children's Hospital Medical Center), Khaled Alganem(University of Toledo), Jarek Meller(Cincinnati Children's Hospital Medical Center), Sadik Khuder(University of Toledo)
Cited by 0
Related Papers
Bilirubin in the Liver–Gut Signaling Axis
|Trends in Endocrinology and Metabolism|2018|254
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
|Neuropsychopharmacology|2013|120
Biliverdin reductase and bilirubin in hepatic disease
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2018|100
Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α
|Journal of Biological Chemistry|2020|97
Signature-based approaches for informed drug repurposing: targeting CNS disorders
|Neuropsychopharmacology|2020|68